Groowe Groowe / Newsroom / NVCR
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVCR News

NovoCure Limited Ordinary Shares

Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth

globenewswire.com
NVCR MRK PFE ABBV

Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strategic Analysis of 23 Industry Players

globenewswire.com
NVCR MRK PFE

Form 8-K

sec.gov
NVCR

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

businesswire.com
NVCR

Novacore Appoints Benjamin Piening as President of Real Estate Segment

prnewswire.com
NVCR

Novocure Announces Optune Lua ® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer

businesswire.com
NVCR

Novocure to Participate in 2026 Leerink Global Healthcare Conference

businesswire.com
NVCR

Form 8-K

sec.gov
NVCR

Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

businesswire.com
NVCR

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026

prnewswire.com
BNTX CRSP NVCR IBRX ONCY